Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
10848 | 962 | 43.1 | 92% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
348 | 16958 | DNA METHYLATION//EPIGENETICS//HISTONE DEACETYLASE INHIBITOR |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | RASSF1A | Author keyword | 86 | 52% | 12% | 116 |
2 | RASSF2 | Author keyword | 19 | 80% | 1% | 12 |
3 | RASSF1 | Author keyword | 16 | 58% | 2% | 18 |
4 | RASSF | Author keyword | 15 | 82% | 1% | 9 |
5 | DLEC1 | Author keyword | 15 | 73% | 1% | 11 |
6 | RASSF1A GENE | Author keyword | 14 | 100% | 1% | 7 |
7 | RASSF2A | Author keyword | 14 | 100% | 1% | 7 |
8 | RASSF10 | Author keyword | 11 | 100% | 1% | 6 |
9 | AG TUMORGENET MED FAK | Address | 11 | 78% | 1% | 7 |
10 | NORE1 | Author keyword | 9 | 83% | 1% | 5 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | RASSF1A | 86 | 52% | 12% | 116 | Search RASSF1A | Search RASSF1A |
2 | RASSF2 | 19 | 80% | 1% | 12 | Search RASSF2 | Search RASSF2 |
3 | RASSF1 | 16 | 58% | 2% | 18 | Search RASSF1 | Search RASSF1 |
4 | RASSF | 15 | 82% | 1% | 9 | Search RASSF | Search RASSF |
5 | DLEC1 | 15 | 73% | 1% | 11 | Search DLEC1 | Search DLEC1 |
6 | RASSF1A GENE | 14 | 100% | 1% | 7 | Search RASSF1A+GENE | Search RASSF1A+GENE |
7 | RASSF2A | 14 | 100% | 1% | 7 | Search RASSF2A | Search RASSF2A |
8 | RASSF10 | 11 | 100% | 1% | 6 | Search RASSF10 | Search RASSF10 |
9 | NORE1 | 9 | 83% | 1% | 5 | Search NORE1 | Search NORE1 |
10 | NORE1A | 9 | 83% | 1% | 5 | Search NORE1A | Search NORE1A |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | EPIGENETIC INACTIVATION | 56 | 24% | 21% | 201 |
2 | 3P213 | 47 | 46% | 8% | 77 |
3 | RASSF1A | 32 | 37% | 7% | 70 |
4 | TUMOR SUPPRESSOR RASSF1A | 32 | 61% | 4% | 34 |
5 | MULTIPLE GENES | 25 | 18% | 13% | 123 |
6 | ABERRANT PROMOTER METHYLATION | 23 | 22% | 10% | 92 |
7 | HUMAN CHROMOSOME 3P213 | 22 | 35% | 5% | 51 |
8 | FREQUENT EPIGENETIC INACTIVATION | 19 | 33% | 5% | 48 |
9 | DOMAIN FAMILY 1A | 17 | 100% | 1% | 8 |
10 | DOMAIN FAMILY PROTEIN | 15 | 77% | 1% | 10 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
The RASSF proteins in cancer; from epigenetic silencing to functional characterization | 2009 | 109 | 144 | 56% |
The RASSF1A tumor suppressor | 2007 | 153 | 126 | 57% |
Role of the ras-association domain family 1 tumor suppressor gene in human cancers | 2005 | 219 | 105 | 69% |
Epigenetic biomarkers in lung cancer | 2014 | 13 | 125 | 29% |
The Ras-association domain family (RASSF) members and their role in human tumourigenesis | 2007 | 104 | 196 | 54% |
RASSF tumor suppressor gene family: Biological functions and regulation | 2014 | 4 | 169 | 53% |
Methylation as a biomarker for head and neck cancer | 2014 | 5 | 73 | 44% |
Lung cancer epigenetics: emerging biomarkers | 2013 | 19 | 110 | 37% |
Colorectal cancer and RASSF familyuA special emphasis on RASSF1A | 2013 | 10 | 92 | 59% |
The role of RASSF1A methylation in cancer | 2007 | 62 | 129 | 59% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | AG TUMORGENET MED FAK | 11 | 78% | 0.7% | 7 |
2 | CRUK MRC OXFORD | 6 | 80% | 0.4% | 4 |
3 | SECT MED MOL GENET | 6 | 17% | 3.1% | 30 |
4 | RENAL MOL ONCOL GRP | 5 | 54% | 0.7% | 7 |
5 | LUNG CANC PROGRAM | 5 | 16% | 2.8% | 27 |
6 | HUMANGENET MED BIOL | 3 | 32% | 0.9% | 9 |
7 | CANC EPIGENET STATE ONCOL SOUTH CHINA | 2 | 67% | 0.2% | 2 |
8 | MED PROTECT ELE OMAGNET RADIATMINIST E | 2 | 67% | 0.2% | 2 |
9 | PROTE SIGNALLING NETWORKS GRP | 2 | 67% | 0.2% | 2 |
10 | UNI BCCS | 2 | 67% | 0.2% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000233078 | DAP KINASE//DEATH ASSOCIATED PROTEIN KINASE//DAPK |
2 | 0.0000215182 | RRBS//CPG ISLANDS//METHYLTRANSFERASE ACTIVITY |
3 | 0.0000196783 | CHFR//EPIGENETCANC//P41 ARC |
4 | 0.0000174414 | RBM5//HUMAN CHROMOSOME 3//LUCA 15 |
5 | 0.0000114265 | T CADHERIN//H CADHERIN//CDH13 |
6 | 0.0000102302 | NGX6//BRD7 GENE//NGX6 GENE |
7 | 0.0000096770 | SW MED SIMMONS CANC//COPY NUMBER LOSS//K RAS GENOTYPES |
8 | 0.0000093105 | CIRCULATING DNA//CELL FREE DNA//CIRCULATING CELL FREE DNA |
9 | 0.0000089037 | P14ARF//P16//P16INK4A |
10 | 0.0000083367 | DNMT3B//DNA METHYLTRANSFERASE//DNMT1 |